Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 15, 2019 - Issue
Submit an article Journal homepage
311
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder

Qijing Bo1 The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing100088, People’s Republic of China;2 Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;3 Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;4 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, People's Republic of ChinaCorrespondence[email protected]
,
Lu Tian1 The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing100088, People’s Republic of China;2 Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;3 Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;4 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, People's Republic of China
,
Feng Li1 The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing100088, People’s Republic of China;2 Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;3 Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;4 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, People's Republic of China
,
Zhen Mao1 The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing100088, People’s Republic of China;2 Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;3 Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;4 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, People's Republic of China
,
Zhimin Wang1 The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing100088, People’s Republic of China;2 Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;3 Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;4 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, People's Republic of China
,
Xin Ma1 The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing100088, People’s Republic of China;2 Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;3 Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;4 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, People's Republic of China
&
Chuanyue Wang1 The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing100088, People’s Republic of China;2 Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;3 Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing 100088, People’s Republic of China;4 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, People's Republic of China
 show all
Pages 1649-1657 | Published online: 24 Jun 2019

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Elias Tesfaye, Chalachew Kassaw & Liyew Agenagnew. (2021) Functional Disability in Patients with Mood Disorders at St Paul’s Hospital Psychiatry Clinic, Addis Ababa, Ethiopia, 2019. Patient Related Outcome Measures 12, pages 181-189.
Read now

Articles from other publishers (19)

Naresh Kumar Trivedi, Raj Gaurang Tiwari, Deden Witarsyah, Vinay Gautam, Alok Misra & Ryan Adhitya Nugraha. (2022) Machine Learning Based Evaluations of Stress, Depression, and Anxiety. Machine Learning Based Evaluations of Stress, Depression, and Anxiety.
Hanife KOCAKAYA, Hatice HARMANCI & Serap YÖRÜBULUT. (2022) Poor quality of life and functioning in euthymic mood disorders. Anatolian Current Medical Journal 4:4, pages 340-348.
Crossref
Daniel C. Jackson, Donald E. McLawhorn, Amy R. Slutzky, Stephen J. Glatt & Robert W. Daly. (2022) Bipolar Disorder, Religion, and Spirituality: A Scoping Review. Journal of Religion and Health 61:5, pages 3589-3614.
Crossref
Youbin Kang, Wooyoung Kang, Kyu-Man Han, Woo-Suk Tae & Byung-Joo Ham. (2022) Associations between cognitive impairment and cortical thickness alterations in patients with euthymic and depressive bipolar disorder. Psychiatry Research: Neuroimaging 322, pages 111462.
Crossref
Tien-Wei Hsu, Che-Sheng Chu, Pao-Yuan Ching, Guan-Wei Chen & Chih-Chuan Pan. (2022) The efficacy and tolerability of memantine for depressive symptoms in major mental diseases: A systematic review and updated meta-analysis of double-blind randomized controlled trials. Journal of Affective Disorders 306, pages 182-189.
Crossref
Rasmus Schwarz, Lone Decker, Ida Seeberg, Kamilla Woznica Miskowiak, Lars Vedel Kessing & Maj Vinberg. (2022) Affective disorders: eliminate WArning signs and REstore functioning—AWARE—a randomised controlled multimodule intervention study, presentation of design and intervention. BMJ Open 12:5, pages e058839.
Crossref
Laurent Boyer, Sara Fernandes, Melanie Faugere, Raphaelle Richieri, Pascal Auquier, Guillaume Fond & Christophe Lancon. (2022) The Validity of the SQoL-18 in Patients with Bipolar and Depressive Disorders: A Psychometric Study from the PREMIUM Project. Journal of Clinical Medicine 11:3, pages 743.
Crossref
Minh Duc NguyenQuoc Vinh NguyenCay Doan HaThanh Van TranLinh Vu Phuong Dang. (2021) Beneficial Effects of Acupuncture as a Complementary Treatment for Patients Receiving Paroxetine For Major Depressive Disorder: A Meta-Analysis. Medical Acupuncture 33:6, pages 420-427.
Crossref
Massimiliano Buoli, Bruno Mario Cesana, Andrea Fagiolini, Umberto Albert, Giuseppe Maina, Andrea de Bartolomeis, Maurizio Pompili, Emi Bondi, Luca SteardoJrJr, Mario Amore, Antonello Bellomo, Alessandro Bertolino, Marco Di Nicola, Guido Di Sciascio, Andrea Fiorillo, Paola Rocca, Emilio Sacchetti, Gabriele Sani, Alberto Siracusano, Giorgio Di Lorenzo, Alfonso Tortorella, Alfredo Carlo Altamura & Bernardo Dell'Osso. (2020) Which factors delay treatment in bipolar disorder? A nationwide study focussed on duration of untreated illness. Early Intervention in Psychiatry 15:5, pages 1136-1145.
Crossref
Teodor T. Postolache, Deborah R. Medoff, Clayton H. Brown, Li Juan Fang, Sanjaya K. Upadhyaya, Christopher A. Lowry, Michael Miller & Julie A. Kreyenbuhl. (2021) Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder. Pteridines 32:1, pages 48-69.
Crossref
Lu Yang, Zhiguo Wu, Lan Cao, Yun Wang, Yousong Su, Jia Huang, Maosheng Fang, Zhijian Yao, Zuowei Wang, Fan Wang, Yuncheng Zhu, Yong Wang, Jun Chen, Daihui Peng & Yiru Fang. (2021) Predictors and moderators of quality of life in patients with major depressive disorder: An AGTs-MDD study report. Journal of Psychiatric Research 138, pages 96-102.
Crossref
Neus Salvat-Pujol, Javier Labad, Mikel Urretavizcaya, Aida De Arriba-Arnau, Cinto Segalàs, Eva Real, Alex Ferrer, José Manuel Crespo, Susana Jiménez-Murcia, Carles Soriano-Mas, José Manuel Menchón & Virginia Soria. (2021) Childhood Maltreatment and Its Interaction with Hypothalamic–Pituitary–Adrenal Axis Activity and the Remission Status of Major Depression: Effects on Functionality and Quality of Life. Brain Sciences 11:4, pages 495.
Crossref
Emma Morton, Venkat Bhat, Peter Giacobbe, Wendy Lou, Erin E. Michalak, Shane McInerney, Trisha Chakrabarty, Benicio N. Frey, Roumen V. Milev, Daniel J. Müller, Sagar V. Parikh, Susan Rotzinger, Sidney H. Kennedy & Raymond W. Lam. (2021) Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. CNS Drugs 35:4, pages 439-450.
Crossref
Giselli Scaini, Samira S. Valvassori, Alexandre P. Diaz, Camila N. Lima, Deborah Benevenuto, Gabriel R. Fries & Joao Quevedo. (2020) Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings. Brazilian Journal of Psychiatry 42:5, pages 536-551.
Crossref
Anne Berghöfer, Luise Martin, Sabrina Hense, Stefan Weinmann & Stephanie Roll. (2020) Quality of life in patients with severe mental illness: a cross-sectional survey in an integrated outpatient health care model. Quality of Life Research 29:8, pages 2073-2087.
Crossref
Fang Wang, Jin Jin, Jun Wang, Ruoqiao He, Kaiyun Li, Xiaonan Hu, Yongchao Li & Yuncheng Zhu. (2020) Association between olfactory function and inhibition of emotional competing distractors in major depressive disorder. Scientific Reports 10:1.
Crossref
Yuriy Mysula. (2020) Comprehensive assessment of the quality of life in primary episode of bipolar affective disorder. Ukrains'kyi Visnyk Psykhonevrolohii:Volume 28, issue 1 (102), pages 60-63.
Crossref
Yu. I. Mysula. (2020) ДЕЯКІ ОСОБЛИВОСТІ ЯКОСТІ ЖИТТЯ ПРИ ПЕРВИННОМУ ЕПІЗОДІ БІПОЛЯРНОГО АФЕКТИВНОГО РОЗЛАДУ. Вісник соціальної гігієни та організації охорони здоров'я України:1, pages 24-30.
Crossref
DishaD Parikh & SmitaN Panse. (2019) Quality of life in elderly bipolar disorder patients. Journal of Geriatric Mental Health 6:2, pages 88.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.